Clarivate PLC (CLVT) Stock AnalysisCLVTStock AnalysisClarivate PLC

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. It operates through three segments, which include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users around the world. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. The Life Sciences & Healthcare segment offers life sciences and healthcare organizations with the contextual intelligence needed to deliver safe and commercial treatments and solutions to patients. It operates in the Industrials sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

Clarivate PLC (CLVT) appears to be a good buy right now due to its current price of $2.02 being significantly lower than the analyst price target of $5. Additionally, the forward P/E ratio of 2.7263 indicates potential for future earnings growth. The recent insider purchase of approximately 900,000 shares at $1.86 suggests strong confidence in the company's recovery, despite a 52% decline in stock price over the past year. However, the main risk is the company's net income loss of $268.6 million in Q2 2026, indicating ongoing profitability challenges.